NIFTY
80.75  0.75%
 10821.85
S&P BSE SENSEX
257.21  0.73%
 35689.6
Cadila Healthcare Ltd.
NSE : CADILAHC BSE : 532321 ISIN code : INE010B01027
on 22-Jun-2018
NSE
-3.1    -0.75%
Rs. 409.20
 
Days Low
Rs. 405.45
Days High
Rs. 414.05

Open Rs. 413.4
 
52 week Low
Rs. 341.65
52 week High
Rs.554.2
 
 
Bid :                 0.00 (0)
Offer :        410.40 (240)
BSE
Rs.410.55
-0.6    -0.15%
on 22-Jun-2018
BSE
-0.6    -0.15%
Rs. 410.55
 
Days Low
Rs. 405.6
Days High
Rs. 414.7

Open Rs. 411.05
 
52 week Low
Rs. 341.2
52 week High
Rs.560
 
 
Bid :                 0.00 (0)
Offer :        410.40 (240)
NSE
Rs.409.20
-3.1    -0.75%
 
 
Last Price (Rs.)  410.55 Value  32083868.00
Net Change (Rs.)  -0.60 Best Buy  0.00
Volume  78100 Best Sell  410.40
Prev.Close (Rs.)  411.15 Best Quantity  0
Open (Rs.)  413.40 Sell Quantity  240
High (Rs.)  414.05 52-Week High (Rs.)  554.20
Low (Rs.)  405.45 52-Week Low (Rs.)  341.65
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  420297.52
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Currents Investments0.00 1009.00 4583.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 576.30 1382731 82.40 0.00 0.35
Cipla 614.00 494387 175.28 50.67 0.49
Piramal Enterprises 2602.35 469965 1186.24 57.81 0.96
Lupin 904.90 409126 349.13 13.01 0.55
Dr. Reddys Lab 2334.95 387539 711.43 27.97 0.86
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2018Dec 2017Sep 2017
Net Sales14551.0015738.0017383.00
Operating Profit4192.004672.007174.00
PBDT3939.004645.006934.00
Net Profit2432.003064.004498.00
More> 
 
Company News
6/19/2018 12:00:00 AM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
6/19/2018 12:00:00 AM
Zydus Cadila gets tentative approval from USFDA for Tadalafil Tablets
6/19/2018 12:00:00 AM
Cadila Healthcare strengthens on the bourses
More>
 
Ratios
   Earnings Per Share (Rs)6.46 
   Book NAV/Share(Rs)64.63 
   PAT Margin (%)20.21 
   Asset Turnover(x)0.30 
   PER(x)68.57 
   Yield(%)0.72 
   EV/Core EBITDA(x)52.51 
   M Cap / Sales14.05 
   Net Sales Growth(%)-54.06 
   PAT Growth(%)-67.51 
   Total Debt/Equity(x)0.44 
   Current Ratio(x)0.71 
   Quick Ratio(x)0.40 
   Total Debt/Mcap(x)0.06 
More>